Potassium citrate and Cyclobenzaprine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium citrate (potassium citrate) and Cyclobenzaprine hydrochloride (cyclobenzaprine hydrochloride). Common drug interactions include diarrhoea among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium citrate and Cyclobenzaprine hydrochloride. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium citrate?

Potassium citrate has active ingredients of potassium citrate. It is often used in kidney stones. eHealthMe is studying from 5,909 Potassium citrate users. Check the latest studies of Potassium citrate.

What is Cyclobenzaprine hydrochloride?

Cyclobenzaprine hydrochloride has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 9,351 Cyclobenzaprine hydrochloride users. Check the latest studies of Cyclobenzaprine hydrochloride.



On Jul, 10, 2026

11 people who take Potassium citrate and Cyclobenzaprine hydrochloride together, and have interactions are studied.

Potassium citrate and Cyclobenzaprine hydrochloride drug interactions.

What are the common drug interactions of Potassium Citrate and Cyclobenzaprine Hydrochloride, by gender? *:

female:

  1. Diarrhoea
  2. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  3. Headache (pain in head)
  4. Infusion related reaction
  5. Irritable bowel syndrome
  6. Ligament sprain (ligament stretched)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Multiple allergies (allergy to multiple agents)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Anxiety
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Cardiomegaly (increased size of heart than normal)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  6. Shoulder operation
  7. Surgery
  8. Urinary tract infection

What are the common drug interactions of Potassium Citrate and Cyclobenzaprine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
  2. Blood cholesterol increased
  3. Blood pressure increased
  4. Insulin resistance
  5. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)

50-59:

  1. Shoulder operation

60+:

  1. Urinary tract infection
  2. Anxiety
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Multiple allergies (allergy to multiple agents)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Nausea (feeling of having an urge to vomit)
  7. Respiratory syncytial virus infection (viral disease of respiratory system)
  8. Sinus congestion (blockage of sinus)
  9. Sinusitis (inflammation of sinus)
  10. Tooth infection

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 4 people, 36.36%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 18.18%
  3. Immunodeficiency Common Variable: 2 people, 18.18%
  4. Retinal Vessel Occlusion (a blockage in one of the small arteries): 1 person, 9.09%
  5. Psoriasis (immune-mediated disease that affects the skin): 1 person, 9.09%
  6. Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 1 person, 9.09%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium citrate and Cyclobenzaprine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium citrate and Cyclobenzaprine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium citrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cyclobenzaprine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium citrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cyclobenzaprine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium citrate and cyclobenzaprine hydrochloride (the active ingredients of Potassium citrate and Cyclobenzaprine hydrochloride, respectively), and Potassium citrate and Cyclobenzaprine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: